The risk of malignancy associated with the use of biological agents in patients with inflammatory bowel disease.
about
Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.Vedolizumab for the treatment of moderately to severely active ulcerative colitis.Oral Cancer and Oral Precancerous Lesions in Inflammatory Bowel Diseases: A Systematic Review.How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease.Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases.Management of Inflammatory Bowel Disease in the Elderly.Next-Generation Therapeutics for Inflammatory Bowel Disease.The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.Acute severe ulcerative colitis: latest evidence and therapeutic implications.
P2860
Q34487787-73C41A6C-4011-4BC2-A115-3591F641B21FQ38425873-6310E639-521A-4B97-8219-A726ECCBAD96Q38545129-6FCB5408-4210-424F-9327-7F374E08CB0DQ38719570-0224B441-043E-48FD-828D-D473C4B3613AQ38805575-A0DD64DC-1FC9-4267-914A-914FED54EFECQ38844393-38C161D2-492C-4866-AC05-5DE648727CA8Q38909523-E8714B89-4325-4E4E-A501-F231A666186EQ40703329-63F0131F-2F80-4572-B06E-0A361FF26E0DQ47427964-7266CCBF-36E8-4982-B401-2F265CB3A002Q49232336-3FE41282-CA45-418B-8CEB-91909698E7C3
P2860
The risk of malignancy associated with the use of biological agents in patients with inflammatory bowel disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The risk of malignancy associa ...... th inflammatory bowel disease.
@en
type
label
The risk of malignancy associa ...... th inflammatory bowel disease.
@en
prefLabel
The risk of malignancy associa ...... th inflammatory bowel disease.
@en
P1476
The risk of malignancy associa ...... th inflammatory bowel disease.
@en
P2093
Corey A Siegel
Parambir S Dulai
P304
P356
10.1016/J.GTC.2014.05.010
P577
2014-06-13T00:00:00Z